Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

1. Roca, J.-M.
2. Alonso, V.
3. Pericay, C.
4. Escudero, P.
5. Salud, A.
6. Losa, F.
7. López, L.-J.
8. Guasch, I.
9. Méndez, M.
10. Quintero-Aldana, G.
11. Grande, C.
12. Vicente, P.
13. Arrivi, A.
14. Martin, C.
15. Moreno, I.
16. García, P.
17. Antón, I.
18. Constenla, M.
19. Yubero, A.
20. Cirera, L.